Свържете се с нас q@h-biota.com O8798O491O
Назад до За специалисти

Използвани материали


1. Lorenzo‐Zúñiga V, Llop E, Suárez C, Álvarez B, Abreu L, Espadaler J, Serra J. I.31, a new combination of probiotics, improves irritable bowel syndrome‐related quality of life. World J Gastroenterol. 2014;20(26):8709–16

2. Barraza‐Ortiz DA, Pérez‐López N, Medina‐López VM, et al. Combination of a Probiotic and an Antispasmodic Increases Quality of Life and Reduces Symptoms in Patients with Irritable Bowel Syndrome: A Pilot Study. Dig Dis. 2021;39(3):294‐300.

3. WGO, Practice Guideline on Probiotics and Prebiotics, 2017: Recommended by Word Gastroenterology Organization to treat IBS.

4. Ivashkin VT, Maev IV, Abdulganieva DI, et al. Practical recommendations of scientific society for the study of human microbiome and the Russian Gastroenterological Association on use of probiotics, prebiotics, synbiotics and functional foods in treatment and prevention of gastroenterological diseases in children and adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 30(2): 76 – 89.

5. Turnbull JL, Adams HN, Gorard DA. Review article: the diagnosis and management of food allergy and food intolerances. Aliment Pharmacol Ther. 2015;41(1):3‐25.

6. Cano Contreras A D, Perez y Lopez N, Minero‐Alfaro J I, Medina‐Lopez V M, Reyes‐Huerta J U. Efficacy of probiotic I3.1 symptomatic improvement in patients with lactose intolerance. Neurogastroenterology & Motility 2019; 31(Suppl.


7. Portincasa P, Celano G, Serale N, et al. Clinical and Metabolomic Effects of Lactiplantibacillus plantarum and Pediococcus acidilactici in Fructose Intolerant Patients. Nutrients. 2022;14(12):2488.

8. Aziz, I., Palsson, O. S., Törnblom, H., Sperber, A. D., Whitehead, W. E., and Simrén, M. (2018). Epidemiology, clinical characteristics, and associations for symptom‐based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross‐sectional population‐based study. Lancet. Gastroenterol. Hepatol. 3, 252–262.

9. Wauters L, Ceulemans M, Schol J, Farré R, Tack J, Vanuytsel T. The Role of Leaky Gut in Functional Dyspepsia. Front Neurosci. 2022;16:851012.

10. Vanheel H, Farré R. Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013;10:142–9.

11. Zhou L, Zeng Y, Zhang H, Ma Y. The Role of Gastrointestinal Microbiota in Functional Dyspepsia: A Review. Front Physiol. 2022;13:910568.

12. Zhang J, Wu HM, Wang X, et al. Efficacy of prebiotics and probiotics for functional dyspepsia: A systematic review and metaanalysis. Medicine (Baltimore). 2020;99(7):e19107.

13. Perez, M., Astó, E., Huedo, P., Alcántara, C., Buj, D. and Espadaler, J. Derived Postbiotics of a Multi‐strain Probiotic Formula Clinically Validated for the Treatment of Irritable Bowel Syndrome. The FASEB Journal, 2020; 34: 1‐1.

14. Vich Vila A, Imhann F, Collij V, et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018;10(472):eaap8914.

15. Abraham B, Quigley EMM. Antibiotics and probiotics in inflammatory bowel disease: when to use them?Frontline Gastroenterology 2020;11:62–69.

16. Lorén V, Manyé J, Fuentes MC, Cabré E, Ojanguren I, Espadaler J. (2017) Comparative Effect of the I3.1 Probiotic Formula in Two Animal Models of Colitis. Probiotics Antimicrob Proteins. 9(1):71–80.

17. Lee KJ. Pharmacologic Agents for Chronic Diarrhea. Intest Res. 2015;13(4):306‐312.

18. Schiller LR, Pardi DS, Sellin JH. Chronic Diarrhea: Diagnosis and Management. Clin Gastroenterol Hepatol. 2017;15(2):182‐ 193.e3.

19. Yang B, Yue Y, Chen Y, et al. Lactobacillus plantarum CCFM1143 Alleviates Chronic Diarrhea via Inflammation Regulation and Gut Microbiota Modulation: A Double‐Blind, Randomized, Placebo‐Controlled Study. Front Immunol. 2021;12:746585.

20. Sato T, Honda S, Tominaga Y, et al. A probiotic blend improves defecation, mental health, and productivity in healthy Japanese volunteers under stressful situations. Heliyon 2022;8(9):e10614.

21. Everhart, J.E.; Ruhl, C.E. Burden of digestive diseases in the United States part II: Lower gastrointestinal diseases. Gastroenterology 2009, 136, 741–754.

22. Schieffer, K.M.; Kline, B.P.; Yochum, G.S.; Koltun, W.A. Pathophysiology of diverticular disease. Expert Rev. Gastroenterol. Hepatol. 2018, 12, 683–692.

23. Bretto E, D'Amico F, Fiore W, Tursi A, Danese S. Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease. J Clin Med. 2022;11(7):1916.

24. Gesualdo M, Rizzi F, Bonetto S, et al. Pancreatic Diseases and Microbiota: A Literature Review and Future Perspectives. J Clin Med. 2020;9(11):3535.

25. Dos Santos PQ, Guedes JC, de Jesus RP, Santos RRD, Fiaconne RL. Effects of using symbiotics in the clinical nutritional evolution of patients with chronic pancreatitis: Study prospective, randomized, controlled, double blind. Clin Nutr ESPEN. 2017;18:9‐15.

26. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double‐blind, placebo‐controlled trial [published correction appears in Lancet.2008 Apr 12;371(9620):1246]. Lancet. 2008;371(9613):651‐659.